Transit Alert: SEPTA is cutting bus, subway, and rail service across Philadelphia. These changes may affect patients, visitors, and staff traveling to and from Fox Chase Cancer Center locations. Read full update.
Fox Chase Goes Live on Facebook to Talk About Skin Cancer
Did you know that sunscreen expires? Would you know what to do if a mark on your skin started changing shape, color, or size? What are the hours when the sun does the most damage to skin?This is the kind of information experts from Fox Chase and the N...
Read More
Fox Chase Goes Live on Facebook to Talk About Skin Cancer
Patients Needed for New Multiple Myeloma Study
In addition to excellent clinical care, Fox Chase Cancer Center is home to a team of world-renowned cancer researchers who develop and test therapies not available anywhere else. For more than a century, Fox Chase has been a key contributor in advancing und...
Read More
Patients Needed for New Multiple Myeloma Study
A New Phase 1 Clinical Trial for Non-Small Cell Lung Cancer
As a National Cancer Institute (NCI)-designated Comprehensive Cancer Center, Fox Chase Cancer Center offers our patients the most advanced treatment options through clinical trials, many of which are not readily available elsewhere. Our nationally ranked do...
Read More
A New Phase 1 Clinical Trial for Non-Small Cell Lung Cancer
Trainee Spotlight: Roshan Thapa, MD
Roshan Thapa, MDPostdoctoral AssociateDr. Siddharth Balachandran’s labFox Chase Cancer [email protected] BiographyContrary to many of my colleagues, my research career started in an unusual, almost accidental manner. After graduat...
Read More
Trainee Spotlight: Roshan Thapa, MD
Preliminary Results Show Interferon-Gamma Holds Promise in Making Immunotherapy a More Effective Cancer Treatment
Immunotherapy has emerged over the past several years as a promising avenue in cancer medicine. Researchers at Fox Chase Cancer Center are in the midst of a Phase 1 clinical trial with support from Horizon Pharma to investigate ways to boost the efficacy of...
Read More
Preliminary Results Show Interferon-Gamma Holds Promise in Making Immunotherapy a More Effective Cancer Treatment
Camille Ragin: A Scientific and Community Leader
In honor of Black History Month, Fox Chase proudly recognizes the work of Camille Ragin, PhD, MPH, for her research on cancer disparities affecting populations of African descent. Among many accomplishments, Ragin, an associate professor in the Cancer...
Read More
Camille Ragin: A Scientific and Community Leader
Share
-
Share with Facebook
-
Share with twitter
-
Share with email
-
Print this